223 related articles for article (PubMed ID: 15625444)
1. LPS-stimulated PMN activation and proinflammatory mediator synthesis is downregulated by phosphodiesterase inhibition: role of pentoxifylline.
Coimbra R; Loomis W; Melbostad H; Tobar M; Porcides RD; Hoyt DB
J Trauma; 2004 Dec; 57(6):1157-63. PubMed ID: 15625444
[TBL] [Abstract][Full Text] [Related]
2. Role of hypertonic saline and pentoxifylline on neutrophil activation and tumor necrosis factor-alpha synthesis: a novel resuscitation strategy.
Coimbra R; Loomis W; Melbostad H; Tobar M; Porcides RD; Lall R; Holbrook T; Hoyt DB
J Trauma; 2005 Aug; 59(2):257-64; discussion 264-5. PubMed ID: 16294063
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase inhibition attenuates stored blood-induced neutrophil activation: a novel adjunct to blood transfusion.
Lall RN; Loomis W; Melbostad H; Hoyt DB; Lane T; Coimbra R
J Am Coll Surg; 2006 Jan; 202(1):10-7. PubMed ID: 16377492
[TBL] [Abstract][Full Text] [Related]
4. Effects of pentoxifylline on human polymorphonuclear neutrophil responses to TNF in whole blood.
Elbim C; Lefebvre M; Hakim J; Gougerot-Pocidalo MA
Eur Cytokine Netw; 1995; 6(2):113-20. PubMed ID: 7578989
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline modulates p47phox activation and downregulates neutrophil oxidative burst through PKA-dependent and -independent mechanisms.
Costantini TW; Deree J; Peterson CY; Putnam JG; Woon T; Loomis WH; Bansal V; Coimbra R
Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):82-91. PubMed ID: 19839729
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil degranulation and the effects of phosphodiesterase inhibition.
Deree J; Lall R; Melbostad H; Grant M; Hoyt DB; Coimbra R
J Surg Res; 2006 Jun; 133(1):22-8. PubMed ID: 16690368
[TBL] [Abstract][Full Text] [Related]
8. In vivo modulation of human neutrophil function by pentoxifylline in patients with septic syndrome.
Oismüller C; Mayer N; Micksche M; Steltzer H; Hammerle AF
Shock; 1995 Sep; 4(3):161-5. PubMed ID: 8574749
[TBL] [Abstract][Full Text] [Related]
9. The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity.
Sullivan GW; Carper HT; Mandell GL
Int J Immunopharmacol; 1995 Oct; 17(10):793-803. PubMed ID: 8707444
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline attenuates stored blood-induced inflammation: A new perspective on an old problem.
Deree J; Lall R; Melbostad H; Loomis W; Hoyt DB; Coimbra R
Surgery; 2006 Aug; 140(2):186-91. PubMed ID: 16904968
[TBL] [Abstract][Full Text] [Related]
11. LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-kappaB, and ICAM-1 expression.
Coimbra R; Melbostad H; Loomis W; Porcides RD; Wolf P; Tobar M; Hoyt DB
J Trauma; 2006 Jan; 60(1):115-25. PubMed ID: 16456445
[TBL] [Abstract][Full Text] [Related]
12. Modulation of immune functions in polymorphonuclear neutrophils induced by physostigmine, but not neostigmine, independent of cholinergic neurons.
Bitzinger DI; Zausig YA; Paech C; Gruber M; Busse H; Sinner B; Graf BM; Trabold B
Immunobiology; 2013 Aug; 218(8):1049-54. PubMed ID: 23434434
[TBL] [Abstract][Full Text] [Related]
13. Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition.
Deree J; Martins JO; Melbostad H; Loomis WH; Coimbra R
Clinics (Sao Paulo); 2008 Jun; 63(3):321-8. PubMed ID: 18568240
[TBL] [Abstract][Full Text] [Related]
14. Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst.
Detmers PA; Zhou D; Polizzi E; Thieringer R; Hanlon WA; Vaidya S; Bansal V
J Immunol; 1998 Aug; 161(4):1921-9. PubMed ID: 9712062
[TBL] [Abstract][Full Text] [Related]
15. [Modulation of the oxidative burst of human neutrophils by pro- and anti-inflammatory cytokines].
Gougerot-Podicalo MA; Elbim C; Chollet-Martin S
Pathol Biol (Paris); 1996 Jan; 44(1):36-41. PubMed ID: 8734298
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways.
Kreth S; Ledderose C; Luchting B; Weis F; Thiel M
Shock; 2010 Jul; 34(1):10-6. PubMed ID: 19997047
[TBL] [Abstract][Full Text] [Related]
17. Adenosine modulation of tumor necrosis factor-alpha-induced neutrophil activation.
Barnes CR; Mandell GL; Carper HT; Luong S; Sullivan GW
Biochem Pharmacol; 1995 Nov; 50(11):1851-7. PubMed ID: 8615864
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline attenuates leukoreduced stored blood-induced neutrophil activation through inhibition of mitogen-activated protein kinases.
Costantini TW; Deree J; Martins JO; Loomis WH; Bansal V; Coimbra R
Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):74-81. PubMed ID: 19697996
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline reduces acute lung injury in chronic endotoxemia.
Michetti C; Coimbra R; Hoyt DB; Loomis W; Junger W; Wolf P
J Surg Res; 2003 Nov; 115(1):92-9. PubMed ID: 14572778
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline inhibits TLR- and inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newborns.
Speer EM; Dowling DJ; Ozog LS; Xu J; Yang J; Kennady G; Levy O
Pediatr Res; 2017 May; 81(5):806-816. PubMed ID: 28072760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
